Zoommed Inc (ZMMDF) 0.0104 $ZMMDF Top 100 Recen
Post# of 273242
Posted On: 05/18/2015 2:08:30 AM
Zoommed Inc (ZMMDF) 0.0104 $ZMMDF
Top 100 Recently Improved Medical Devices/Technology/Supplies Companies 2015 - News, financial/non-financial information and stock market analysis
M2 - Tue Mar 24, 7:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wq6xl5/global_recently) has announced the addition of the "Global Recently Improved Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 Recently Improved medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. As price pressures increase, medical device makers need to rethink product development processes. Design to Value can help get costs under control and deliver exactly what customers value. The sector has always been challenging, with increasingly complex technologies and tough quality and regulatory hurdles. Until recently, however, device makers who overcame those barriers could sell their products at prices that made the effort worthwhile. Today, medical device companies operate in a different world. In developed countries, healthcare systems are under acute financial pressure. Healthcare providers are responding by exploring every opportunity to increase efficiencies and reduce costs. Developing economies are transforming the environment, too. As growth slows in established markets, opportunities are arising elsewhere. A rapidly growing middle class is demanding more medical devices of all types, but price sensitivity in these markets is acute. Report Highlights: - Global Recently Improved 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Recently Improved medical devices/technology/supplies companies with foreign companies - International presence of Global Recently Improved medical devices/technology/supplies companies - Key R&D activities by Global Recently Improved medical devices/technology/supplies companies Companies Mentioned (Partial List) - Aigan Co., Ltd. (Japan) - Alterola Biotech, Inc. (United States) - Ambu A/S (Denmark) - Amedica Corp (United States) - Delcath Systems Incorporated (United States) - Dexcom, Inc. (United States) - Ginko International Co Ltd (Taiwan) - Gruppo Luxottica S.p.A. (Italy) - Karolinska Development AB (Sweden) - Lumenis Ltd (United States) - Newmax Technology Company Limited (Taiwan) - Nolato AB (Sweden) - Ohara Inc (Japan) - Sartorius Stedim Biotech Sa (France) - Straumann Holding AG (Switzerland) - Varian Medical Systems, Inc. (United States) - VWR Corp (United States) - Zeltiq Aesthetics Inc (United States) - ZoomMed Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/wq...l_recently
ZLTQ: 28.92 (+0.08), VWR: 27.40 (+0.08), VAR: 87.25 (-0.34), LMNS: 11.15 (-0.02), DCTH: 0.83 (-0.03), AMDA: 0.22 (unch)
ZoomMed Announces the Grant of Options
Marketwired - Mon Jan 19, 2:50PM CST
ZoomMed inc. (TSX VENTURE: ZMD) announces that during a Board of directors held on January 16, 2015, the Board agreed to grant 4,900,000 stock options to its directors and officers and 2,700,000 stock options to its employees and consultants, taking effect on January 19, 2015.
ZMD.VN: 0.020 (unch)
Annual and Special Shareholders Meeting of ZoomMed Inc.
Marketwired - Fri Nov 28, 11:09AM CST
ZoomMed Inc. (TSX VENTURE: ZMD), announces it has held its Annual and Special Meeting of Shareholders as at November 28, 2014.
ZMD.VN: 0.020 (unch)
ZoomMed Inc.: Filing of the Annual Financial Statements
Marketwired - Fri Oct 17, 3:18PM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces that it has proceed today with the filing of its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014.
ZMD.VN: 0.020 (unch)
ZoomMed Inc.: Update Regarding the Filing of the Annual Financial Statements
Marketwired - Fri Oct 10, 3:11PM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces that its Board of Directors and its officers are near to finalize, with its external auditors, its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014 (collectively, the "Annual Financial Statements 2014"
. The Board of Directors of the Corporation and its officers expect to proceed quickly in order to fulfill the obligations of the Corporation in regards with the release of the Annual Financial Statements 2014. The Corporation expects being able to release its Annual Financial Statements 2014 on October 17, 2014.
ZMD.VN: 0.020 (unch)
As a Result of its Recent Sale of Assets, ZoomMed Announces a Delay in the Filing of its Annual Financial Statements
Marketwire - Fri Sep 26, 11:14AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces it should be unable to release on time its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014 (collectively, the "Annual Financial Statements 2014" .
ZMD.VN: 0.020 (unch)
IIROC Trade Resumption - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 9:01AM CDT
Trading resumes in:
ZoomMed Sells Interest in its ZRx Prescriber to TELUS Health for the Canadian Market for Up to $6,800,000
Marketwire - Wed Sep 03, 8:54AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed has sold an interest in the technology underlying its ZRx Prescriber Technology and certain related Canadian operations to TELUS Health for up to $6,800,000 which will allow ZoomMed's team to continue its worldwide distribution of its unique prescriber, with ongoing priority focus on the U.S. market. TELUS Health is Canada's largest Electronic Medical Records (EMR) provider and a leader in the Canadian claims and benefits management sector.
ZMD.VN: 0.020 (unch)
IIROC Trade Halt - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 7:38AM CDT
The following issues have been halted by IIROC:
Top 100 Recently Improved Medical Devices/Technology/Supplies Companies 2015 - News, financial/non-financial information and stock market analysis
M2 - Tue Mar 24, 7:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wq6xl5/global_recently) has announced the addition of the "Global Recently Improved Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 Recently Improved medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. As price pressures increase, medical device makers need to rethink product development processes. Design to Value can help get costs under control and deliver exactly what customers value. The sector has always been challenging, with increasingly complex technologies and tough quality and regulatory hurdles. Until recently, however, device makers who overcame those barriers could sell their products at prices that made the effort worthwhile. Today, medical device companies operate in a different world. In developed countries, healthcare systems are under acute financial pressure. Healthcare providers are responding by exploring every opportunity to increase efficiencies and reduce costs. Developing economies are transforming the environment, too. As growth slows in established markets, opportunities are arising elsewhere. A rapidly growing middle class is demanding more medical devices of all types, but price sensitivity in these markets is acute. Report Highlights: - Global Recently Improved 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Recently Improved medical devices/technology/supplies companies with foreign companies - International presence of Global Recently Improved medical devices/technology/supplies companies - Key R&D activities by Global Recently Improved medical devices/technology/supplies companies Companies Mentioned (Partial List) - Aigan Co., Ltd. (Japan) - Alterola Biotech, Inc. (United States) - Ambu A/S (Denmark) - Amedica Corp (United States) - Delcath Systems Incorporated (United States) - Dexcom, Inc. (United States) - Ginko International Co Ltd (Taiwan) - Gruppo Luxottica S.p.A. (Italy) - Karolinska Development AB (Sweden) - Lumenis Ltd (United States) - Newmax Technology Company Limited (Taiwan) - Nolato AB (Sweden) - Ohara Inc (Japan) - Sartorius Stedim Biotech Sa (France) - Straumann Holding AG (Switzerland) - Varian Medical Systems, Inc. (United States) - VWR Corp (United States) - Zeltiq Aesthetics Inc (United States) - ZoomMed Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/wq...l_recently
ZLTQ: 28.92 (+0.08), VWR: 27.40 (+0.08), VAR: 87.25 (-0.34), LMNS: 11.15 (-0.02), DCTH: 0.83 (-0.03), AMDA: 0.22 (unch)
ZoomMed Announces the Grant of Options
Marketwired - Mon Jan 19, 2:50PM CST
ZoomMed inc. (TSX VENTURE: ZMD) announces that during a Board of directors held on January 16, 2015, the Board agreed to grant 4,900,000 stock options to its directors and officers and 2,700,000 stock options to its employees and consultants, taking effect on January 19, 2015.
ZMD.VN: 0.020 (unch)
Annual and Special Shareholders Meeting of ZoomMed Inc.
Marketwired - Fri Nov 28, 11:09AM CST
ZoomMed Inc. (TSX VENTURE: ZMD), announces it has held its Annual and Special Meeting of Shareholders as at November 28, 2014.
ZMD.VN: 0.020 (unch)
ZoomMed Inc.: Filing of the Annual Financial Statements
Marketwired - Fri Oct 17, 3:18PM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces that it has proceed today with the filing of its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014.
ZMD.VN: 0.020 (unch)
ZoomMed Inc.: Update Regarding the Filing of the Annual Financial Statements
Marketwired - Fri Oct 10, 3:11PM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces that its Board of Directors and its officers are near to finalize, with its external auditors, its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014 (collectively, the "Annual Financial Statements 2014"
. The Board of Directors of the Corporation and its officers expect to proceed quickly in order to fulfill the obligations of the Corporation in regards with the release of the Annual Financial Statements 2014. The Corporation expects being able to release its Annual Financial Statements 2014 on October 17, 2014. ZMD.VN: 0.020 (unch)
As a Result of its Recent Sale of Assets, ZoomMed Announces a Delay in the Filing of its Annual Financial Statements
Marketwire - Fri Sep 26, 11:14AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces it should be unable to release on time its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014 (collectively, the "Annual Financial Statements 2014"
. ZMD.VN: 0.020 (unch)
IIROC Trade Resumption - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 9:01AM CDT
Trading resumes in:
ZoomMed Sells Interest in its ZRx Prescriber to TELUS Health for the Canadian Market for Up to $6,800,000
Marketwire - Wed Sep 03, 8:54AM CDT
ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed has sold an interest in the technology underlying its ZRx Prescriber Technology and certain related Canadian operations to TELUS Health for up to $6,800,000 which will allow ZoomMed's team to continue its worldwide distribution of its unique prescriber, with ongoing priority focus on the U.S. market. TELUS Health is Canada's largest Electronic Medical Records (EMR) provider and a leader in the Canadian claims and benefits management sector.
ZMD.VN: 0.020 (unch)
IIROC Trade Halt - ZoomMed inc.
Newsfile Corp - Wed Sep 03, 7:38AM CDT
The following issues have been halted by IIROC:
(0)
(0)Scroll down for more posts ▼